32 Citations (Scopus)

Abstract

Human immunodeficiency virus type-one (HIV- 1)-associated dementia (HAD) is manifested as a spectrum of behavioral, motor and cognitive dysfunctions. The disorder commonly occurs during late stage HIV disease and remains an important complication despite highly active antiretroviral therapies. A metabolic encephalopathy, fueled by neurotoxic secretions from brain mononuclear phagocytes (MP) (macrophages and microglia) underlies HIV- I neuropathogenesis. One pivotal question, however, is how brain MP evolve from neurotrophic to neurotoxic cells. The interplay between the virus, the macrophage and the neuron has just recently begun to be unraveled. Along with a multitude of other MP secretory products, chemokines effect neuronal function by engaging neuronal receptors then activating pathways that alter synaptic transmission, cell growth, injury and protection. Both neurons and glia secrete chemokines. Interestingly, HIV-1 and its gene products can mimic chemokine neuronal signaling by binding to neuronal chemokine receptors or by other non-specific mechanisms. The elucidation of mechanisms involved in chemokine-mediated neural compromise will likely provide unique insights into the pathogenesis and treatment, not only of HAD, but of a wide range of neurodegenerative disorders.

Original languageEnglish (US)
Pages (from-to)137-150
Number of pages14
JournalCellular and molecular biology (Noisy-le-Grand, France)
Volume48
Issue number2
StatePublished - Mar 2002

Fingerprint

Macrophages
Chemokines
Dementia
HIV-1
Phagocytes
Wounds and Injuries
Viruses
Neurons
Brain
Metabolic Brain Diseases
HIV
Chemokine Receptors
Highly Active Antiretroviral Therapy
Microglia
Cell growth
Synaptic Transmission
Neuroglia
Neurodegenerative Diseases
Genes
Growth

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Cell Biology

Cite this

Macrophages, chemokines and neuronal injury in HIV-1-associated dementia. / Ryan, Lisa A.; Cotter, Robin L.; Zink, Walter E.; Gendelman, Howard Eliot; Zheng, Jialin C.

In: Cellular and molecular biology (Noisy-le-Grand, France), Vol. 48, No. 2, 03.2002, p. 137-150.

Research output: Contribution to journalReview article

@article{48e61cde173f4868bffdd3d2dd34a41c,
title = "Macrophages, chemokines and neuronal injury in HIV-1-associated dementia.",
abstract = "Human immunodeficiency virus type-one (HIV- 1)-associated dementia (HAD) is manifested as a spectrum of behavioral, motor and cognitive dysfunctions. The disorder commonly occurs during late stage HIV disease and remains an important complication despite highly active antiretroviral therapies. A metabolic encephalopathy, fueled by neurotoxic secretions from brain mononuclear phagocytes (MP) (macrophages and microglia) underlies HIV- I neuropathogenesis. One pivotal question, however, is how brain MP evolve from neurotrophic to neurotoxic cells. The interplay between the virus, the macrophage and the neuron has just recently begun to be unraveled. Along with a multitude of other MP secretory products, chemokines effect neuronal function by engaging neuronal receptors then activating pathways that alter synaptic transmission, cell growth, injury and protection. Both neurons and glia secrete chemokines. Interestingly, HIV-1 and its gene products can mimic chemokine neuronal signaling by binding to neuronal chemokine receptors or by other non-specific mechanisms. The elucidation of mechanisms involved in chemokine-mediated neural compromise will likely provide unique insights into the pathogenesis and treatment, not only of HAD, but of a wide range of neurodegenerative disorders.",
author = "Ryan, {Lisa A.} and Cotter, {Robin L.} and Zink, {Walter E.} and Gendelman, {Howard Eliot} and Zheng, {Jialin C}",
year = "2002",
month = "3",
language = "English (US)",
volume = "48",
pages = "137--150",
journal = "Cellular and Molecular Biology",
issn = "0145-5680",
publisher = "Cellular and Molecular Biology Association",
number = "2",

}

TY - JOUR

T1 - Macrophages, chemokines and neuronal injury in HIV-1-associated dementia.

AU - Ryan, Lisa A.

AU - Cotter, Robin L.

AU - Zink, Walter E.

AU - Gendelman, Howard Eliot

AU - Zheng, Jialin C

PY - 2002/3

Y1 - 2002/3

N2 - Human immunodeficiency virus type-one (HIV- 1)-associated dementia (HAD) is manifested as a spectrum of behavioral, motor and cognitive dysfunctions. The disorder commonly occurs during late stage HIV disease and remains an important complication despite highly active antiretroviral therapies. A metabolic encephalopathy, fueled by neurotoxic secretions from brain mononuclear phagocytes (MP) (macrophages and microglia) underlies HIV- I neuropathogenesis. One pivotal question, however, is how brain MP evolve from neurotrophic to neurotoxic cells. The interplay between the virus, the macrophage and the neuron has just recently begun to be unraveled. Along with a multitude of other MP secretory products, chemokines effect neuronal function by engaging neuronal receptors then activating pathways that alter synaptic transmission, cell growth, injury and protection. Both neurons and glia secrete chemokines. Interestingly, HIV-1 and its gene products can mimic chemokine neuronal signaling by binding to neuronal chemokine receptors or by other non-specific mechanisms. The elucidation of mechanisms involved in chemokine-mediated neural compromise will likely provide unique insights into the pathogenesis and treatment, not only of HAD, but of a wide range of neurodegenerative disorders.

AB - Human immunodeficiency virus type-one (HIV- 1)-associated dementia (HAD) is manifested as a spectrum of behavioral, motor and cognitive dysfunctions. The disorder commonly occurs during late stage HIV disease and remains an important complication despite highly active antiretroviral therapies. A metabolic encephalopathy, fueled by neurotoxic secretions from brain mononuclear phagocytes (MP) (macrophages and microglia) underlies HIV- I neuropathogenesis. One pivotal question, however, is how brain MP evolve from neurotrophic to neurotoxic cells. The interplay between the virus, the macrophage and the neuron has just recently begun to be unraveled. Along with a multitude of other MP secretory products, chemokines effect neuronal function by engaging neuronal receptors then activating pathways that alter synaptic transmission, cell growth, injury and protection. Both neurons and glia secrete chemokines. Interestingly, HIV-1 and its gene products can mimic chemokine neuronal signaling by binding to neuronal chemokine receptors or by other non-specific mechanisms. The elucidation of mechanisms involved in chemokine-mediated neural compromise will likely provide unique insights into the pathogenesis and treatment, not only of HAD, but of a wide range of neurodegenerative disorders.

UR - http://www.scopus.com/inward/record.url?scp=0036516741&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036516741&partnerID=8YFLogxK

M3 - Review article

C2 - 11995633

AN - SCOPUS:0036516741

VL - 48

SP - 137

EP - 150

JO - Cellular and Molecular Biology

JF - Cellular and Molecular Biology

SN - 0145-5680

IS - 2

ER -